Cite
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
MLA
Lee, Che-Jui, et al. “Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 ‘CREATE’ Trial.” International Journal of Molecular Sciences, vol. 23, no. 10, May 2022. EBSCOhost, https://doi.org/10.3390/ijms23105689.
APA
Lee, C.-J., Modave, E., Boeckx, B., Kasper, B., Aamdal, S., Leahy, M. G., Rutkowski, P., Bauer, S., Debiec-Rychter, M., Sciot, R., Lambrechts, D., Wozniak, A., & Schöffski, P. (2022). Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial. International Journal of Molecular Sciences, 23(10). https://doi.org/10.3390/ijms23105689
Chicago
Lee, Che-Jui, Elodie Modave, Bram Boeckx, Bernd Kasper, Steinar Aamdal, Michael G Leahy, Piotr Rutkowski, et al. 2022. “Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 ‘CREATE’ Trial.” International Journal of Molecular Sciences 23 (10). doi:10.3390/ijms23105689.